PTGS2 and neoplasm: For example, HAd5/3-Cox2L-D24 utilizes the tumor-specific cyclooxygenase 2 gene promoter to control E1A expression, to further enforce tumor selectivity.112 The vector design demonstrated safety and extended virus circulation in patients with metastatic and refractory solid tumors.